Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
GGZ
|
Bruce N Alpert
President |
SELL
Other acquisition or disposition
|
Indirect | 1,000 Reduced 100.0% |
$25,000
$25.0 p/Share
|
Feb 28
2022 |
|
CANE
|
Sal Gilbertie
CEO |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 86.96% |
$59,020
$29.51 p/Share
|
Feb 28
2022 |
|
CANE
|
Sal Gilbertie
CEO |
SELL
Open market or private sale
|
Indirect | 100 Reduced 100.0% |
$2,703
$27.03 p/Share
|
Feb 28
2022 |
|
CANE
|
Sal Gilbertie
CEO |
SELL
Open market or private sale
|
Indirect | 200 Reduced 100.0% |
$1,758
$8.79 p/Share
|
Feb 28
2022 |
|
CANE
|
Sal Gilbertie
CEO |
SELL
Open market or private sale
|
Direct | 400 Reduced 57.06% |
$9,676
$24.19 p/Share
|
Feb 28
2022 |
|
CANE
|
Sal Gilbertie
CEO |
SELL
Open market or private sale
|
Indirect | 200 Reduced 66.45% |
$4,922
$24.61 p/Share
|
Feb 28
2022 |
|
ISBC
|
P. Sean Burke
EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 4,432 Reduced 2.56% |
$74,945
$16.91 p/Share
|
Feb 28
2022 |
|
ISBC
|
Richard Spengler
Senior EVP |
SELL
Payment of exercise price or tax liability
|
Direct | 6,138 Reduced 1.06% |
$103,794
$16.91 p/Share
|
Feb 28
2022 |
|
APRE
|
Eyal C. Attar
SVP, Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 36,000 Reduced 43.37% |
$62,280
$1.73 p/Share
|
Feb 28
2022 |
|
PETV
|
James Rudolph Martin
Director |
BUY
Open market or private purchase
|
Direct | 7,500 Added 7.38% |
$11,400
$1.52 p/Share
|
Feb 28
2022 |
|
NAVB
|
Amit Bhalla
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,500 Added 4.71% |
-
|
Feb 28
2022 |
|
NAVB
|
Alexander L Cappello
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,500 Added 5.1% |
-
|
Feb 28
2022 |
|
NAVB
|
John K Scott Jr. |
BUY
Grant, award, or other acquisition
|
Direct | 2,500 Added 0.03% |
-
|
Feb 28
2022 |
|
NAVB
|
Malcolm G Witter
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,500 Added 1.71% |
-
|
Feb 28
2022 |
|
IRIX
|
Patrick Mercer
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 85 Reduced 0.15% |
$379
$4.46 p/Share
|
Feb 28
2022 |
|
OMQS
|
Shai Shalom Lustgarten
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect | 40,000 Added 4.16% |
-
|
Feb 28
2022 |
|
OMQS
|
Neev Nissenson
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 20,000 Added 29.72% |
-
|
Feb 28
2022 |
|
TYME
|
Michael Demurjian
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 0.08% |
$6,200
$0.31 p/Share
|
Feb 28
2022 |
|
LMPX
|
Samer Tawfik
President and CEO |
SELL
Open market or private sale
|
Indirect | 9,000 Reduced 0.89% |
$40,500
$4.5 p/Share
|
Feb 28
2022 |
|
CXDO
|
Anil K. Puri |
BUY
Exercise of conversion of derivative security
|
Direct | 10,000 Added 29.85% |
$40,800
$4.08 p/Share
|
Feb 28
2022 |
|
CXDO
|
Anil K. Puri |
SELL
Payment of exercise price or tax liability
|
Direct | 9,294 Reduced 39.55% |
$40,801
$4.39 p/Share
|
Feb 28
2022 |
|
CXDO
|
Steven G Mihaylo |
BUY
Open market or private purchase
|
Direct | 3,000 Added 0.03% |
$13,260
$4.42 p/Share
|
Feb 28
2022 |
|
VBFC
|
George R. Whittemore
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 157 Added 9.07% |
$3,969
$25.28 p/Share
|
Feb 28
2022 |
|
SNSE
|
Cambrian Bio Pharma Inc |
BUY
Open market or private purchase
|
Direct | 42 Added 0.0% |
$151
$3.6 p/Share
|
Feb 28
2022 |
|
SNSE
|
James Peyer |
BUY
Open market or private purchase
|
Indirect | 42 Added 0.0% |
$151
$3.6 p/Share
|
Feb 28
2022 |
|
SAL
|
Amy D Raymond
EVP Chief Retail Lending Offr. |
BUY
Grant, award, or other acquisition
|
Direct | 200 Added 50.0% |
$11,332
$56.66 p/Share
|
Feb 28
2022 |
|
SAL
|
Carla L Balesano
EVP, Chief Credit Officer |
BUY
Grant, award, or other acquisition
|
Direct | 500 Added 50.0% |
$28,330
$56.66 p/Share
|
Feb 28
2022 |
|
SAL
|
John Matthew Davies
President of NY Region & CLO |
BUY
Grant, award, or other acquisition
|
Direct | 1,200 Added 50.0% |
$67,992
$56.66 p/Share
|
Feb 28
2022 |
|
SAL
|
Peter Albero
EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 1,750 Added 50.0% |
$99,155
$56.66 p/Share
|
Feb 28
2022 |
|
SAL
|
Richard J Cantele Jr
President and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 2,800 Added 50.0% |
$158,648
$56.66 p/Share
|
Feb 28
2022 |
|
SAL
|
Steven M Essex
EVP and Head of Trust |
BUY
Grant, award, or other acquisition
|
Direct | 200 Added 50.0% |
$11,332
$56.66 p/Share
|
Feb 28
2022 |
|
SAL
|
Todd M Clinton
EVP & Chief Risk Officer |
BUY
Grant, award, or other acquisition
|
Direct | 500 Added 50.0% |
$28,330
$56.66 p/Share
|
Feb 28
2022 |
|
SAL
|
Todd J Rubino
EVP, Chief Comm. Lndg. Off. |
BUY
Grant, award, or other acquisition
|
Direct | 900 Added 50.0% |
$50,994
$56.66 p/Share
|
Feb 28
2022 |
|
PCTI
|
David A Neumann
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 11,020 Added 3.45% |
$54,218
$4.92 p/Share
|
Feb 28
2022 |
|
PCTI
|
David A Neumann
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 3,130 Reduced 1.02% |
$15,400
$4.92 p/Share
|
Feb 28
2022 |
|
PCTI
|
Kevin J Mc Gowan
Vice President and CFO |
BUY
Grant, award, or other acquisition
|
Direct | 5,893 Added 3.29% |
$28,994
$4.92 p/Share
|
Feb 28
2022 |
|
PCTI
|
Kevin J Mc Gowan
Vice President and CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 2,039 Reduced 1.18% |
$10,032
$4.92 p/Share
|
Feb 28
2022 |
|
PCTI
|
Rishi Bharadwaj
Senior VP and COO |
BUY
Grant, award, or other acquisition
|
Direct | 6,697 Added 2.77% |
$32,949
$4.92 p/Share
|
Feb 28
2022 |
|
PCTI
|
Rishi Bharadwaj
Senior VP and COO |
SELL
Payment of exercise price or tax liability
|
Direct | 2,318 Reduced 0.99% |
$11,405
$4.92 p/Share
|
Feb 28
2022 |
|
PCTI
|
Shelley J Bacastow
Senior VP, Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct | 5,761 Added 5.47% |
$28,344
$4.92 p/Share
|
Feb 28
2022 |
|
PCTI
|
Shelley J Bacastow
Senior VP, Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,994 Reduced 2.0% |
$9,810
$4.92 p/Share
|
Feb 28
2022 |
|
PCTI
|
Les Sgnilek
VP, Corp Res & Chief Risk Off |
BUY
Grant, award, or other acquisition
|
Direct | 4,376 Added 4.45% |
$21,530
$4.92 p/Share
|
Feb 28
2022 |
|
PCTI
|
Les Sgnilek
VP, Corp Res & Chief Risk Off |
SELL
Payment of exercise price or tax liability
|
Direct | 1,515 Reduced 1.61% |
$7,454
$4.92 p/Share
|
Feb 28
2022 |
|
PCTI
|
Sumeet Singh Paul
Vice President and CIO |
BUY
Grant, award, or other acquisition
|
Direct | 4,666 Added 6.0% |
$22,957
$4.92 p/Share
|
Feb 28
2022 |
|
PCTI
|
Sumeet Singh Paul
Vice President and CIO |
SELL
Payment of exercise price or tax liability
|
Direct | 1,615 Reduced 2.21% |
$7,946
$4.92 p/Share
|
Feb 28
2022 |
|
PCTI
|
Suzanne Cafferty
VP - Global Marketing |
BUY
Grant, award, or other acquisition
|
Direct | 3,738 Added 12.1% |
$18,391
$4.92 p/Share
|
Feb 28
2022 |
|
PCTI
|
Suzanne Cafferty
VP - Global Marketing |
SELL
Payment of exercise price or tax liability
|
Direct | 1,294 Reduced 4.76% |
$6,366
$4.92 p/Share
|
Feb 28
2022 |
|
GALT
|
Joel Lewis
President and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 9,358 Added 95.54% |
$17,499
$1.87 p/Share
|
Feb 28
2022 |
|
DRTT
|
Steven Parry
Director |
BUY
Open market or private purchase
|
Direct | 5,000 Added 11.82% |
$8,750
$1.75 p/Share
|
Feb 28
2022 |
|
CMTV
|
David Mark Bouffard |
BUY
Open market or private purchase
|
Direct | 300 Added 14.13% |
$6,585
$21.95 p/Share
|
Feb 28
2022 |